- Research works
- 4 ▼ 100% vs 2013–17
- Citations
- 123 30.8 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Moximed (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Moximed (United States) publish most on?
By volume in 2022–2025: Microtubule and mitosis dynamics, Neurogenesis and neuroplasticity mechanisms and Glioma Diagnosis and Treatment.
- 1 Microtubule and mitosis dynamics Cell Biology 0 works
- 2 Neurogenesis and neuroplasticity mechanisms Developmental Neuroscience 0 works
- 3 Glioma Diagnosis and Treatment Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Moximed (United States)'s research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hayward
- California State University, East Bay
- Biolog (United States)
- X-ray Instrumentation Associates (United States)
- Planet Biotechnology (United States)
- Advanced Cell Diagnostics (United States)
- Sepragen Corporation (United States)
- Kaiser Permanente Hayward Medical Center
- Abeam Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.